Clinical trial
"Heptovax" - A Phase II, Open-Label Trial Evaluating the Safety and Efficacy of GV1001 in Advanced Hepatocellular Carcinoma.
NCT00444782 is registered in ClinicalTrials.gov with Pharmexa A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "Heptovax" - A Phase II, Open-Label Trial Evaluating the Safety and Efficacy of GV1001 in Advanced Hepatocellular Carcinoma.
- Lead sponsor
- Pharmexa A/S
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- April 30, 2008
- Enrollment
- 41 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.